Amylx Pharmaceuticals Inc vs Core Scientific Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Core Scientific Inc trades at $21.28 (market cap $6.35B). The key difference: Core Scientific Inc is far larger — about 2.4× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Core Scientific Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | CORZ | |
|---|---|---|
Market Cap | $2.64B | $6.35B |
Sector | Health | Technology |
52-Week High | $24.19 | $29.16 |
52-Week Low | $7.82 | $13.55 |
Enterprise Value | $2.39B | $8.88B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →